Jump to content

EIF4G2

From Wikipedia, the free encyclopedia

EIF4G2
Available structures
PDBOrtholog search:PDBeRCSB
Identifiers
AliasesEIF4G2,AAG1, DAP5, NAT1, P97, eukaryotic translation initiation factor 4 gamma 2
External IDsOMIM:602325;MGI:109207;HomoloGene:37477;GeneCards:EIF4G2;OMA:EIF4G2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001418
NM_001042559
NM_001172705

NM_001040131
NM_013507

RefSeq (protein)

NP_001036024
NP_001166176
NP_001409

NP_001035221
NP_038535

Location (UCSC)Chr 11: 10.8 – 10.81 MbChr 7: 110.67 – 110.68 Mb
PubMedsearch[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Eukaryotic translation initiation factor 4 gamma 2(also calledp97,NAT1,andDAP-5) is aproteinthat in humans is encoded by theEIF4G2gene.[5][6]

Function

[edit]

Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by the eIF4G2 gene shares similarity with the C-terminal region of eIF4G1 that contains the binding sites for eIF4A andeIF3.eIF4G2 additionally contains a binding site for eIF4E at the N-terminus. Unlike eIF4G1, which supports cap-dependent and independent translation, the eIF4G2 gene product functions as a general repressor of translation by forming translationally inactive complexes. In vitro and in vivo studies indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. Alternatively spliced transcript variants encoding different isoforms of this gene have been described.[7]

Interactions

[edit]

EIF4G2 has been shown tointeractwithEIF3A.[8][9]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000110321Ensembl,May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000005610Ensembl,May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Yamanaka S, Poksay KS, Arnold KS, Innerarity TL (March 1997)."A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme".Genes Dev.11(3): 321–33.doi:10.1101/gad.11.3.321.PMID9030685.
  6. ^Levy-Strumpf N, Deiss LP, Berissi H, Kimchi A (March 1997)."DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death".Mol. Cell. Biol.17(3): 1615–25.doi:10.1128/mcb.17.3.1615.PMC231887.PMID9032289.
  7. ^"Entrez Gene: EIF4G2 eukaryotic translation initiation factor 4 gamma, 2".
  8. ^Gradi A, Imataka H, Svitkin YV, Rom E, Raught B, Morino S, Sonenberg N (January 1998)."A novel functional human eukaryotic translation initiation factor 4G".Mol. Cell. Biol.18(1): 334–42.doi:10.1128/mcb.18.1.334.PMC121501.PMID9418880.
  9. ^Henis-Korenblit S, Strumpf NL, Goldstaub D, Kimchi A (January 2000)."A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation".Mol. Cell. Biol.20(2): 496–506.doi:10.1128/MCB.20.2.496-506.2000.PMC85113.PMID10611228.

Further reading

[edit]